KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Recursion Pharmaceuticals (RXRX) Long-Term Debt Issuances (2020)

Recursion Pharmaceuticals (RXRX) has disclosed Long-Term Debt Issuances for 1 consecutive years, with $400000.0 as the latest value for Q2 2020.

  • For the quarter ending Q2 2020, Long-Term Debt Issuances changed N/A year-over-year to $400000.0, compared with a TTM value of $400000.0 through Mar 2021, changed N/A, and an annual FY2020 reading of $6.4 million, down 46.16% over the prior year.
  • Long-Term Debt Issuances was $400000.0 for Q2 2020 at Recursion Pharmaceuticals, down from $6.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $6.0 million in Q1 2020 and bottomed at $400000.0 in Q2 2020.